Hemodynamic and hormonal effects of human ghrelin in healthy volunteers.
By N. Nagaya, M. Kojima, Masaaki Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi, K. Kangawa. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 2001
621 citations recorded by the source corpus.
Subfields: Endocrine and Autonomic Systems, Nutrition and Dietetics, Physiology
View Paper: https://www.semanticscholar.org/paper/6c1879f8e4e68b612d9c64f4186405f23d014bd2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrine and Autonomic Systems
In Nutrition and Dietetics
In Physiology
Citations in the corpus
- Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. (2004, background): “The presence of GHS-R 1a mRNA has been demonstrated in heart and aorta (22, 38), and specific binding sites for ghrelin have been recently identified in rat heart and human arteries, where the density of ghrelin receptors is up-regulated with atherosclerosis (405).”
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT (2002, methodology): “Recent evidence indicates that ghrelin and synthetic GHS feature a variety of cardiovascular activities, including increase of myocardial contractility (Bisi et al., 1999; Nagaya et al., 2001a), vasodilatation (Okumura et al.”
- Ghrelin: structure and function. (2005, background): “(89, 169), and intravenous injection of ghrelin into human”